1. Home
  2. CDRE vs IOVA Comparison

CDRE vs IOVA Comparison

Compare CDRE & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadre Holdings Inc.

CDRE

Cadre Holdings Inc.

HOLD

Current Price

$42.38

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.87

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDRE
IOVA
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
968.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CDRE
IOVA
Price
$42.38
$2.87
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
$34.50
$10.45
AVG Volume (30 Days)
231.9K
11.3M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
0.90%
N/A
EPS Growth
33.82
N/A
EPS
1.11
N/A
Revenue
$619,068,000.00
$250,425,000.00
Revenue This Year
$12.51
$60.71
Revenue Next Year
$8.21
$59.52
P/E Ratio
$38.25
N/A
Revenue Growth
19.94
175.62
52 Week Low
$27.07
$1.64
52 Week High
$46.64
$8.15

Technical Indicators

Market Signals
Indicator
CDRE
IOVA
Relative Strength Index (RSI) 51.61 69.64
Support Level $40.22 $2.08
Resistance Level $43.33 $2.60
Average True Range (ATR) 1.42 0.16
MACD -0.08 0.06
Stochastic Oscillator 43.03 90.80

Price Performance

Historical Comparison
CDRE
IOVA

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: